Synthesis and In Vitro Evaluation as Potential Anticancer and Antioxidant Agents of Diphenylamine-Pyrrolidin-2-one-Hydrazone Derivatives

The title compounds were synthesized by the reaction of 5-oxo-1-(4-(phenylamino)phenyl)pyrrolidine-3-carbohydrazide with various aldehydes bearing aromatic and heterocyclic moieties and acetophenones, and their cytotoxicity was tested via MTT assay against human triple-negative breast cancer MDA-MB-...

Full description

Bibliographic Details
Main Authors: Irma Zubrickė, Ilona Jonuškienė, Kristina Kantminienė, Ingrida Tumosienė, Vilma Petrikaitė
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/23/16804
_version_ 1797400023253647360
author Irma Zubrickė
Ilona Jonuškienė
Kristina Kantminienė
Ingrida Tumosienė
Vilma Petrikaitė
author_facet Irma Zubrickė
Ilona Jonuškienė
Kristina Kantminienė
Ingrida Tumosienė
Vilma Petrikaitė
author_sort Irma Zubrickė
collection DOAJ
description The title compounds were synthesized by the reaction of 5-oxo-1-(4-(phenylamino)phenyl)pyrrolidine-3-carbohydrazide with various aldehydes bearing aromatic and heterocyclic moieties and acetophenones, and their cytotoxicity was tested via MTT assay against human triple-negative breast cancer MDA-MB-231, human melanoma IGR39, human pancreatic carcinoma Panc-1, and prostate cancer cell line PPC-1. Furthermore, the selectivity of compounds towards cancer cells compared to fibroblasts was also investigated. Four compounds were identified as the most promising anticancer agents out of a series of pyrrolidinone-hydrazone derivatives bearing a diphenylamine moiety. These compounds were most selective against the prostate cancer cell line PPC-1 and the melanoma cell lines IGR39, with EC<sub>50</sub> values in the range of 2.5–20.2 µM against these cell lines. In general, the compounds were less active against triple-negative breast cancer MDA-MB-231 cell line, and none of them showed an inhibitory effect on the migration of these cells. In the ‘wound healing’ assay, <i>N</i>′-((5-nitrothiophen-2-yl)methylene)-5-oxo-1-(4-(phenylamino)phenyl)pyrrolidine-3-carbohydrazide was identified as the most promising derivative that could be further developed as an antimetastatic agent. <i>N</i>′-(5-chloro- and <i>N</i>′-(3,4-dichlorobenzylidene)-5-oxo-1-(4-(phenylamino)phenyl)pyrrolidine-3-carbohydrazides most efficiently reduced the cell viability in IGR39 cell spheroids, while there was no effect of the investigated pyrrolidinone-hydrazone derivatives on PPC-1 3D cell cultures. Antioxidant activity determined via FRAP assay of <i>N</i>′-(1-(4-aminophenyl)ethylidene)-5-oxo-1-(4-(phenylamino)phenyl)pyrrolidine-3-carbohydrazide was 1.2 times higher than that of protocatechuic acid.
first_indexed 2024-03-09T01:49:34Z
format Article
id doaj.art-1061b754a9984d3d93ff1360f3968864
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T01:49:34Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-1061b754a9984d3d93ff1360f39688642023-12-08T15:17:12ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-11-0124231680410.3390/ijms242316804Synthesis and In Vitro Evaluation as Potential Anticancer and Antioxidant Agents of Diphenylamine-Pyrrolidin-2-one-Hydrazone DerivativesIrma Zubrickė0Ilona Jonuškienė1Kristina Kantminienė2Ingrida Tumosienė3Vilma Petrikaitė4Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, 50254 Kaunas, LithuaniaDepartment of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, 50254 Kaunas, LithuaniaDepartment of Physical and Inorganic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, 50254 Kaunas, LithuaniaDepartment of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, 50254 Kaunas, LithuaniaLaboratory of Drug Targets Histopathology, Institute of Cardiology, Lithuanian University of Health Sciences, Sukilėlių pr. 13, 50162 Kaunas, LithuaniaThe title compounds were synthesized by the reaction of 5-oxo-1-(4-(phenylamino)phenyl)pyrrolidine-3-carbohydrazide with various aldehydes bearing aromatic and heterocyclic moieties and acetophenones, and their cytotoxicity was tested via MTT assay against human triple-negative breast cancer MDA-MB-231, human melanoma IGR39, human pancreatic carcinoma Panc-1, and prostate cancer cell line PPC-1. Furthermore, the selectivity of compounds towards cancer cells compared to fibroblasts was also investigated. Four compounds were identified as the most promising anticancer agents out of a series of pyrrolidinone-hydrazone derivatives bearing a diphenylamine moiety. These compounds were most selective against the prostate cancer cell line PPC-1 and the melanoma cell lines IGR39, with EC<sub>50</sub> values in the range of 2.5–20.2 µM against these cell lines. In general, the compounds were less active against triple-negative breast cancer MDA-MB-231 cell line, and none of them showed an inhibitory effect on the migration of these cells. In the ‘wound healing’ assay, <i>N</i>′-((5-nitrothiophen-2-yl)methylene)-5-oxo-1-(4-(phenylamino)phenyl)pyrrolidine-3-carbohydrazide was identified as the most promising derivative that could be further developed as an antimetastatic agent. <i>N</i>′-(5-chloro- and <i>N</i>′-(3,4-dichlorobenzylidene)-5-oxo-1-(4-(phenylamino)phenyl)pyrrolidine-3-carbohydrazides most efficiently reduced the cell viability in IGR39 cell spheroids, while there was no effect of the investigated pyrrolidinone-hydrazone derivatives on PPC-1 3D cell cultures. Antioxidant activity determined via FRAP assay of <i>N</i>′-(1-(4-aminophenyl)ethylidene)-5-oxo-1-(4-(phenylamino)phenyl)pyrrolidine-3-carbohydrazide was 1.2 times higher than that of protocatechuic acid.https://www.mdpi.com/1422-0067/24/23/16804diphenylaminepyrrolidin-2-onemelanomaprostate tumortriple-negative breast cancerpancreatic tumor
spellingShingle Irma Zubrickė
Ilona Jonuškienė
Kristina Kantminienė
Ingrida Tumosienė
Vilma Petrikaitė
Synthesis and In Vitro Evaluation as Potential Anticancer and Antioxidant Agents of Diphenylamine-Pyrrolidin-2-one-Hydrazone Derivatives
International Journal of Molecular Sciences
diphenylamine
pyrrolidin-2-one
melanoma
prostate tumor
triple-negative breast cancer
pancreatic tumor
title Synthesis and In Vitro Evaluation as Potential Anticancer and Antioxidant Agents of Diphenylamine-Pyrrolidin-2-one-Hydrazone Derivatives
title_full Synthesis and In Vitro Evaluation as Potential Anticancer and Antioxidant Agents of Diphenylamine-Pyrrolidin-2-one-Hydrazone Derivatives
title_fullStr Synthesis and In Vitro Evaluation as Potential Anticancer and Antioxidant Agents of Diphenylamine-Pyrrolidin-2-one-Hydrazone Derivatives
title_full_unstemmed Synthesis and In Vitro Evaluation as Potential Anticancer and Antioxidant Agents of Diphenylamine-Pyrrolidin-2-one-Hydrazone Derivatives
title_short Synthesis and In Vitro Evaluation as Potential Anticancer and Antioxidant Agents of Diphenylamine-Pyrrolidin-2-one-Hydrazone Derivatives
title_sort synthesis and in vitro evaluation as potential anticancer and antioxidant agents of diphenylamine pyrrolidin 2 one hydrazone derivatives
topic diphenylamine
pyrrolidin-2-one
melanoma
prostate tumor
triple-negative breast cancer
pancreatic tumor
url https://www.mdpi.com/1422-0067/24/23/16804
work_keys_str_mv AT irmazubricke synthesisandinvitroevaluationaspotentialanticancerandantioxidantagentsofdiphenylaminepyrrolidin2onehydrazonederivatives
AT ilonajonuskiene synthesisandinvitroevaluationaspotentialanticancerandantioxidantagentsofdiphenylaminepyrrolidin2onehydrazonederivatives
AT kristinakantminiene synthesisandinvitroevaluationaspotentialanticancerandantioxidantagentsofdiphenylaminepyrrolidin2onehydrazonederivatives
AT ingridatumosiene synthesisandinvitroevaluationaspotentialanticancerandantioxidantagentsofdiphenylaminepyrrolidin2onehydrazonederivatives
AT vilmapetrikaite synthesisandinvitroevaluationaspotentialanticancerandantioxidantagentsofdiphenylaminepyrrolidin2onehydrazonederivatives